Remove Pharma Companies Remove Pharmacy Remove Vaccine
article thumbnail

Can J&Jā€™s vaccine approval erase bad pharma?

World of DTC Marketing

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? The answer is NO.

article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients ā€” and especially the pharma companies that promote them ā€” but a wrong long-term value for healthcare costs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Neglected tropical diseases: non-profits lead the way as private sectors lags

Pharmaceutical Technology

While private pharma companies also take part in such efforts, their efforts has largely been limited to donating assets or distributing treatments. In Muratovā€™s opinion, this was reflective of a wider pattern seen in almost any other field of research, which could now change with the development of Covid-19 vaccines and antivirals.

article thumbnail

Healthcare that no longer leaves out the patient

pharmaphorum

Thanks to the convergence of tech and health, the future of healthcare places the patient directly in the driver seat, able to track their health stats, monitor and manage conditions, engage with providers and connect with pharmacies all within a digital platform. About the author. Omri Shor is the CEO of Medisafe.

article thumbnail

Pharmaā€™s climate change vulnerability and opportunity

pharmaphorum

Rising global temperatures will, for example, enhance the spread of mosquito-borne diseases like malaria and Zika, increasing the need for effective vaccines. Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. ā€œAny Vulnerability . Making plans is not enough.

article thumbnail

To help solve patient distrust in pharma, industry collaboration is key

pharmaphorum

Pharma companies are now household names, having been thrust into the publicā€™s consciousness after dominating the headlines through the pandemic. These efforts, as Nadhim Zahawi rightly said when he was Vaccines Minister, have led to the life sciences and pharma industry becoming a UK national treasure.

article thumbnail

On Clinical Trials Day, CVS shares lessons learned from one year providing trial services

pharmaphorum

In recent years the retail pharmacy chain has begun to delve more and more deeply into the healthcare sector ā€“ by constantly expanding the basic healthcare services offered at their instore Minute Clinics, and by buying into the health insurance insurance space with their $69 billion purchase of Aetna in 2017.